(1)
To Evaluate the Effect of Ranolazine on Fasting Plasma Glucose in Patients of Type II Diabetes Mellitus With Stable Angina As Add on Therapy. Int J of Biomed & Adv Res 2013, 4 (10), 690-694. https://doi.org/10.7439/ijbar.v4i10.508.